The Prostacyclin International Expert Panel developed consensus opinions on common clinical scenarios in which they considered adding an oral prostacyclin pathway agent in pulmonary arterial hypertension (PAH) patients. This interactive, Virtual Learning Theater will feature a group of the authors who will discuss the results of the consensus survey. This is a non-CME educational program…

In this interactive live symposium, expert faculty will dissect patient cases that address best practices for recognizing, diagnosing, and treating pulmonary arterial hypertension (PAH) in clinical practice. Learners will gain insight into evidence-based approaches to risk assessment, setting treatment goals, and tailoring therapy to meet treatment goals to improve patient outcomes.

Severe asthma is associated with increased risk of morbidity and mortality. This Medscape symposium will bring an asthma patient case to life using a Virtual Patient Simulation platform. Attendees will be able to contribute to the patient journey at key decision points, vote on clinical actions, and receive expert faculty feedback.